DVLP Medicines
Founded 2022 · 11 employees on LinkedIn · 1 known investors
Find your way into DVLP Medicines
343 people in our graph share verified history with the DVLP Medicines team — schools, employers, funds. One of them is your warm intro.
Aydin Senkutunlockedknows Patrick Perry · together at The Wharton School (overlapped)
knows the team · via University of Chicago
×3knows the team · via Yale University
×3knows the team · via The Wharton School
×2knows the team · via National Institute of Allergy and Infectious Diseases (NIAID)
knows the team · via Icahn School of Medicine at Mount Sinai
DVLP is a biotechnology company developing vaccine platforms using artificial intelligence, synthetic biology, and immunology. The company appears to focus on next-generation vaccine development beyond mRNA technologies.
Founders & leadership
DVLP Medicines was founded in 2022 by Patrick Perry and Jason Paragas.
PP
Patrick PerryinCo-founder / CFO / GMPatrick Perry served in investment management and business development roles, most recently at Geode Capital where he led institutional client relationships and helped grow assets under management across multiple asset classes. He is now co-founder and CFO of DVLP Medicines, a biotechnology company developing vaccine platforms.
JP
Board
MK
Mehmood KhanChairman of the Board
Investors · 1
In the news
Frequently asked questions
- What does DVLP Medicines do?
- DVLP is a biotechnology company developing vaccine platforms using artificial intelligence, synthetic biology, and immunology. The company appears to focus on next-generation vaccine development beyond mRNA technologies.
- Who founded DVLP Medicines?
- DVLP Medicines was founded by Patrick Perry, Jason Paragas in 2022.
- Who are DVLP Medicines's investors?
- DVLP Medicines's investors include DCVC (Data Collective).